Abstract
Loss of genetic material, including loss of loci on chromosome arms 6q, 9p, and 10q, occurs frequently in cutaneous melanoma but infrequently in benign melanocytic nevi or other melanocytic lesions, suggesting that these genetic alterations are important in the development and progression of melanoma. To examine whether allelic loss is of prognostic importance in melanoma, disease-free survival was related to loss of heterozygosity on 6q, 9p and 10q in 83 individuals with sporadic primary cutaneous melanoma. Loss of chromosome arms 6q and 10q were each significantly associated with a poorer clinical outcome (P=0.013 and P=0.001 respectively). In a subgroup of 41 subjects whose primary tumours were allelotyped, the fractional allelic loss (FAL) at 39 autosomal arms also significantly correlated with disease-free survival (P=0.013), with an increase in FAL associated with a poorer outcome; this association remained significant when controlled for tumour thickness (P=0.035). In addition, a greater proportion of cells were immunopositive for Ki67 antigen, p53 and p21WAF1 protein in the primary melanomas than in the benign melanocytic nevi, however, only p53 over-expression was significantly associated with improved survival (P=0.041).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Healy, E., Belgaid, C., Takata, M. et al. Prognostic significance of allelic losses in primary melanoma. Oncogene 16, 2213–2218 (1998). https://doi.org/10.1038/sj.onc.1200203
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1200203
Keywords
This article is cited by
-
Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology
Cancer and Metastasis Reviews (2022)
-
BRN2 is a non-canonical melanoma tumor-suppressor
Nature Communications (2021)
-
Comment on “Absence of Senescence-Associated β-Galactosidase Activity in Human Melanocytic Nevi In Vivo”
Journal of Investigative Dermatology (2008)
-
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
British Journal of Cancer (2006)
-
PTEN/MMAC1 expression in melanoma resection specimens
British Journal of Cancer (2002)